tldrdaily.news logo

Failed ALS Drug Relyvrio to be Pulled from Market by Amylyx

1 min read
Source: ABC News
TL;DR Summary

Amylyx Pharmaceuticals will pull its drug Relyvrio from the US market after a study showed it didn't benefit patients with ALS. The company will halt sales and marketing in the US and Canada, and new patients will no longer be able to get a prescription. Patients already taking the therapy can enroll in a program to receive it for free. The drug's failure is a disappointment for patients and advocates, leaving just three ALS medicines available to US patients. Amylyx also plans to lay off 70% of its employees and continue studying Relyvrio and another experimental drug for rare diseases.

Topics:business#als#amylyx-pharmaceuticals#drug-withdrawal#fda#health-medicine#relyvrio
Share this article
  1. ALS drug will be pulled from US market after study showed patients didn't benefit  ABC News
  2. A.L.S. Drug Relyvrio Will Be Taken Off the Market, Its Maker Says  The New York Times
  3. Amylyx will remove ALS drug from the market after failed trial  The Washington Post
  4. Amylyx to pull failed ALS drug Relyvrio from market, cut 70% of staffers  FiercePharma
  5. Amylyx to pull ALS drug from market, cut 70% of staff  STAT

Reading Insights

Total Reads

0

Unique Readers

1

Time Saved

2 min

vs 3 min read

Condensed

82%

555 → 100 words

Want the full story? Read the original article

Read on ABC News